13
Oct

Eisai and partner Helsinn secured the FDA’s blessing to market Akynzeo, a combination treatment designed to prevent nasuea and vomiting among cancer patients undergoing chemotherapy.

…read more

Source: Eisai wins FDA nod for a drug to treat chemo-caused nausea

    

0 No comments